Literature DB >> 32460385

COVID-19 health restrictions in a transplanted Italian cohort.

Marco Maria Pascale1, Giuseppe Bianco1, Lorenzo Ferri2, Salvatore Agnes1,2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32460385      PMCID: PMC7283751          DOI: 10.1111/tri.13661

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.842


× No keyword cloud information.
Dear Editor, An exponential diffusion of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) prompted Italian institutions to take extraordinary healthcare restrictive measures since March 8, 2020, declaring quarantine for COVID‐19 [1]. The whole population had to adapt to new limits, which were interestingly in line with the postdischarge indications given to liver recipients (LRs) in our Transplant Center. The aim of this work was to analyze the tolerance to the health restrictions of LRs, comparing them with the rest of the Italian population. We investigated the compliance of the 96 consecutive LRs discharged between January 2017 and March 2020 from our Center. Then, we created a web‐based national survey, spread via social media, in order to create a standard of quarantine compliance involving the nontransplant population from all over Italy with an age ≥18 years (Fig. S1). Furthermore, we performed a subgroup analysis between LRs and the nontransplanted population living in the same regions as LRs (local control group, LCG), in order to decrease bias related to the incidence of COVID‐19 across Italy. All data were analyzed using chi‐square test and Student’s t‐test. We created a survey with 510 participants who gave their informed consent to the survey. In particular, we enrolled 76 LRs and 434 nontransplanted individuals. From the latter population, we obtained the LCG with 202 individuals. Liver recipients’ response rate was 79.2%. The response rate of the nontransplant population cannot be calculated due to the way the survey is administered. The LRs were confirmed to be older than the nontransplant population (median age 58 years vs. 44.5 years, P < 0.001), with more male individuals among LRs than in the nontransplant population (81.6% vs. 30.9%, P < 0.001), in line with the data in the literature [2] (Table 1A).
Table 1

Results of comparison analysis. (A) Comparison of LRs with nontransplant population and subgroup analysis with local control group. (B) Subgroup analysis for PPE compliance, according to the maximum period of social distancing ≤15 days or ≥30 days.

(A)
Liver recipients (n = 76)Nontransplant population (n = 434) P valueLocal control group (n = 202) P value
Median age, years5844.5<0.00144.5<0.001
Male sex, n (%)62 (81.6%)134 (30.9%)<0.00158 (28.7%)<0.001
Maximum period of social distancing
0–14 days, n (%)31 (40.8%)207 (47.7%)0.397 (48%)0.3
15–30 days, n (%)23 (30.2%)106 (24.4%)0.348 (23.8%)0.3
>30 days, n (%)22 (29%)121 (27.9%)0.957 (28.2%)0.9
Social distancing interruption reason
Purchases, n (%)n.d.280 (64.5%)133 (65.8%)
Work, n (%)n.d.74 (17.1%)30 (14.9%)
Pet care, n (%)n.d.34 (7.8%)16 (7.9%)
Other, n (%)n.d.46 (10.6%)23 (11.4%)
Use of PPE
Always, n (%)72 (94.7%)330 (76%)<0.001149 (73.8%)<0.001
Sometimes, n (%)4 (5.3%)68 (15.7%)0.0236 (17.8%)0.008
Never, n (%)0 (0%)36 (8.3%)0.00917 (8.4%)0.009
Swab test, n (%)5 (6.6%)8 (1.8%)0.026 (2.9%)0.2
Positive swab test, n (%)1 (1.3%)4 (0.9%)3 (1.5%)

n.d, no data; n, number; PPE, personal protective equipment.

Results of comparison analysis. (A) Comparison of LRs with nontransplant population and subgroup analysis with local control group. (B) Subgroup analysis for PPE compliance, according to the maximum period of social distancing ≤15 days or ≥30 days. n.d, no data; n, number; PPE, personal protective equipment. Social distancing was respected homogeneously in all three time ranges examined (0–14, 15–30, >30 days), by both the LRs and the nontransplant population; no differences were found also comparing the LRs with the LCG. Indeed, the low rate of SARS‐CoV2 swab tests recorded in both the LRs and the nontransplant population (6.6% and 1.8%, respectively) was in favor of a good self‐isolating. A continuous use of the personal protective equipment (PPE) was present in 94.7% among LRs, compared with 76% in the nontransplant population (P < 0.001) and 73.8% in the LCG (P < 0.001). In the subgroup analysis (Table 1B), among participants respecting a maximum social distancing ≥30 days, the LRs reported a greater constant use of PPE than the nontransplant population (100% vs. 78.8%, P = 0.02) and the LCG (100% vs. 80.6%, P = 0.02). Also, in the subgroup analysis among participants with a maximum social distancing ≤15 days, the continuous use of PPE is higher in LRs (94.3%), than in the nontransplant population (70.6%, P = 0.003) and the LCG (66.7%, P = 0.001). Liver recipients are a population at high risk of infection [3]. A strict outpatient follow‐up and an increased awareness in LRs about prevention measures are fundamental to reduce post‐transplant complications [4]. Liver recipients manage to consider health restrictions as a useful instrument, acquiring a fundamental advantage in a pandemic. In our series, LRs prove high levels of tolerance with COVID‐19‐related restrictions, partly explaining lower incidence of SARS‐CoV‐2 infection in transplant population [5]. Our data also confirm the good compliance of the nontransplant population, too. The main limit of this work is the monocentric design with LRs out of the area with the highest COVID‐19 incidence. The compliance of the population with the social distancing measures is fundamental to reduce the spread of SARS‐CoV‐2 [6, 7]. The tolerance of a high‐risk group can be used as a benchmark.

Conflict of interest

The authors of this manuscript have no conflicts of interest to disclose as described by Transplant International.

Funding

The authors have declared no funding. Figure S1. Distribution of survey participants from all over Italian regions, in relation with COVID‐19 incidence (updated to 7th May [1]). Click here for additional data file.
  5 in total

Review 1.  Respiratory viruses in transplant recipients: more than just a cold. Clinical syndromes and infection prevention principles.

Authors:  Salma Abbas; Jillian E Raybould; Sangeeta Sastry; Oveimar de la Cruz
Journal:  Int J Infect Dis       Date:  2017-07-22       Impact factor: 3.623

2.  OPTN/SRTR 2017 Annual Data Report: Liver.

Authors:  W R Kim; J R Lake; J M Smith; D P Schladt; M A Skeans; S M Noreen; A M Robinson; E Miller; J J Snyder; A K Israni; B L Kasiske
Journal:  Am J Transplant       Date:  2019-02       Impact factor: 8.086

3.  Infections in liver and lung transplant recipients: a national prospective cohort.

Authors:  Carlo Gagliotti; Filomena Morsillo; Maria Luisa Moro; Lucia Masiero; Francesco Procaccio; Francesca Vespasiano; Annalisa Pantosti; Monica Monaco; Giulia Errico; Andrea Ricci; Paolo Grossi; Alessandro Nanni Costa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-29       Impact factor: 3.267

4.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

5.  First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study.

Authors:  Jonathan Tschopp; Arnaud G L'Huillier; Matteo Mombelli; Nicolas J Mueller; Nina Khanna; Christian Garzoni; Dario Meloni; Matthaios Papadimitriou-Olivgeris; Dionysios Neofytos; Hans H Hirsch; Macé M Schuurmans; Thomas Müller; Thierry Berney; Jürg Steiger; Manuel Pascual; Oriol Manuel; Christian van Delden
Journal:  Am J Transplant       Date:  2020-06-09       Impact factor: 9.369

  5 in total
  3 in total

Review 1.  The Impact of the SARS-CoV-2 Pandemic on Healthcare Provision in Italy to non-COVID Patients: a Systematic Review.

Authors:  Gianmarco Lugli; Matteo Maria Ottaviani; Annarita Botta; Guido Ascione; Alessandro Bruschi; Federico Cagnazzo; Lorenzo Zammarchi; Paola Romagnani; Tommaso Portaluri
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-01-01       Impact factor: 2.576

2.  Incidence, Characteristics, and Outcome of COVID-19 in Adults on Kidney Replacement Therapy: A Regionwide Registry Study.

Authors:  Johan De Meester; Dirk De Bacquer; Maarten Naesens; Bjorn Meijers; Marie M Couttenye; An S De Vriese
Journal:  J Am Soc Nephrol       Date:  2020-11-05       Impact factor: 10.121

3.  Suspension and resumption of kidney transplant programmes during the COVID-19 pandemic: perspectives from patients, caregivers and potential living donors - a qualitative study.

Authors:  Chandana Guha; Allison Tong; Amanda Baumgart; Nicole Scholes-Robertson; Nicole Isbel; John Kanellis; Scott Campbell; Toby Coates; Steven Chadban
Journal:  Transpl Int       Date:  2020-07-29       Impact factor: 3.842

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.